U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 284

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr18:29098182-29178638
TTR, DSG2Arrhythmogenic right ventricular dysplasia 10, Amyloidogenic transthyretin amyloidosisUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr18:29175076
GRCh38:
Chr18:31595113
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Dec 9, 2021)
criteria provided, single submitter
3.
GRCh37:
Chr18:29178533
GRCh38:
Chr18:31598570
TTRAmyloidogenic transthyretin amyloidosisUncertain significance
(Sep 7, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr18:29171919
GRCh38:
Chr18:31591956
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(May 3, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr18:29171940
GRCh38:
Chr18:31591977
TTRAmyloidogenic transthyretin amyloidosisUncertain significance
(Jun 23, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr18:29175150
GRCh38:
Chr18:31595187
TTRK90QAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Apr 30, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr18:29175117
GRCh38:
Chr18:31595154
TTRT79AAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Apr 9, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr18:29175090
GRCh38:
Chr18:31595127
TTRS70GAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Oct 13, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr18:29172908
GRCh38:
Chr18:31592945
TTRV40AAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Jul 19, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr18:29172855
GRCh38:
Chr18:31592892
TTRCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisLikely benign
(Feb 24, 2023)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr18:29178515
GRCh38:
Chr18:31598552
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Jan 26, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr18:29178571
GRCh38:
Chr18:31598608
TTRT126NAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Mar 8, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr18:29172954
GRCh38:
Chr18:31592991
TTRK55NAmyloidogenic transthyretin amyloidosisPathogenic
(Sep 22, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr18:29172937
GRCh38:
Chr18:31592974
TTRV50LAmyloidogenic transthyretin amyloidosisPathogenic
(Jul 2, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr18:29172936
GRCh38:
Chr18:31592973
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Apr 3, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr18:29171928
GRCh38:
Chr18:31591965
TTRP22fsAmyloidogenic transthyretin amyloidosisUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr18:29171910
GRCh38:
Chr18:31591947
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Mar 15, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr18:29178628
GRCh38:
Chr18:31598665
TTRP145HAmyloidogenic transthyretin amyloidosis, not providedUncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr18:29171900
GRCh38:
Chr18:31591937
TTRA12VAmyloidogenic transthyretin amyloidosisUncertain significance
(Feb 6, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr18:29178544
GRCh38:
Chr18:31598581
TTRA117DAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Dec 24, 2021)
criteria provided, single submitter
21.
GRCh37:
Chr18:29172952
GRCh38:
Chr18:31592989
TTRK55EAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Dec 21, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr18:29172850
GRCh38:
Chr18:31592887
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Oct 10, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr18:29175133
GRCh38:
Chr18:31595170
TTRF84YAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Jul 7, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr18:29172963
GRCh38:
Chr18:31593000
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Jun 30, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr18:29175217
GRCh38:
Chr18:31595254
TTRE112GAmyloidogenic transthyretin amyloidosisUncertain significance
(Jun 28, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr18:29172897
GRCh38:
Chr18:31592934
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Jun 3, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr18:29178602
GRCh38:
Chr18:31598639
TTRY136*Amyloidogenic transthyretin amyloidosisUncertain significance
(Oct 21, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr18:29175073
GRCh38:
Chr18:31595110
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Jan 7, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr18:29178584
GRCh38:
Chr18:31598621
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Oct 10, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr18:29172973
GRCh38:
Chr18:31593010
TTRE62KAmyloidogenic transthyretin amyloidosis, not providedUncertain significance
(Mar 27, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr18:29178577
GRCh38:
Chr18:31598614
TTRA128Vnot provided, Cardiovascular phenotype, Amyloidogenic transthyretin amyloidosis
Uncertain significance
(Apr 20, 2023)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr18:29175114
GRCh38:
Chr18:31595151
TTRL78VAmyloidogenic transthyretin amyloidosisUncertain significance
(Dec 10, 2021)
no assertion criteria provided
33.
GRCh37:
Chr18:29175094
GRCh38:
Chr18:31595131
TTRE71ACardiovascular phenotype, Amyloidogenic transthyretin amyloidosisUncertain significance
(Jun 16, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr18:29178561
GRCh38:
Chr18:31598598
TTRR123GAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypeUncertain significance
(Jun 21, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr18:29172899
GRCh38:
Chr18:31592936
TTRL37PAmyloidogenic transthyretin amyloidosisUncertain significance
(Sep 29, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr18:29175198
GRCh38:
Chr18:31595235
TTRP106AAmyloidogenic transthyretin amyloidosisUncertain significance
(Jul 22, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr18:29175102-29175103
GRCh38:
Chr18:31595139-31595140
TTRE74LAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic/Likely pathogenic
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr18:29171886
GRCh38:
Chr18:31591923
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Jan 21, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr18:29173003
GRCh38:
Chr18:31593040
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Apr 24, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr18:29178605
GRCh38:
Chr18:31598642
TTRCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisLikely benign
(Aug 5, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr18:29173009
GRCh38:
Chr18:31593046
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Apr 12, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr18:29172854
GRCh38:
Chr18:31592891
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Nov 13, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr18:29175073
GRCh38:
Chr18:31595110
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Sep 4, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr18:29171946
GRCh38:
Chr18:31591983
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Oct 13, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr18:29171947
GRCh38:
Chr18:31591984
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Nov 24, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr18:29172840
GRCh38:
Chr18:31592877
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Nov 30, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr18:29173004
GRCh38:
Chr18:31593041
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Aug 26, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr18:29173006
GRCh38:
Chr18:31593043
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(May 19, 2021)
criteria provided, single submitter
49.
GRCh37:
Chr18:29178590
GRCh38:
Chr18:31598627
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Dec 1, 2020)
criteria provided, single submitter
50.
GRCh37:
Chr18:29175236
GRCh38:
Chr18:31595273
TTRHyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome 1,
Amyloidogenic transthyretin amyloidosis
Likely benign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr18:29175105
GRCh38:
Chr18:31595142
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Sep 1, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr18:29175210
GRCh38:
Chr18:31595247
TTRH110DCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisConflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr18:29175103
GRCh38:
Chr18:31595140
TTRE74AAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Aug 28, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr18:29172874
GRCh38:
Chr18:31592911
TTRK29EAmyloidogenic transthyretin amyloidosisUncertain significance
(Sep 10, 2021)
criteria provided, single submitter
55.
GRCh37:
Chr18:29175178
GRCh38:
Chr18:31595215
TTRW99SAmyloidogenic transthyretin amyloidosisUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr18:29172880
GRCh38:
Chr18:31592917
TTRP31SAmyloidogenic transthyretin amyloidosisUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr18:29172878
GRCh38:
Chr18:31592915
TTRC30YAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Aug 28, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr18:29171930
GRCh38:
Chr18:31591967
TTRP22LCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisUncertain significance
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr18:29171877
GRCh38:
Chr18:31591914
TTRH4QAmyloidogenic transthyretin amyloidosisUncertain significance
(Aug 4, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr18:29172962
GRCh38:
Chr18:31592999
TTRD58VAmyloidogenic transthyretin amyloidosisPathogenic
(Mar 5, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr18:29175088
GRCh38:
Chr18:31595125
TTRT69IAmyloidogenic transthyretin amyloidosisPathogenic
(Aug 26, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr18:29175193
GRCh38:
Chr18:31595230
TTRI104TAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic/Likely pathogenic
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr18:29175082
GRCh38:
Chr18:31595119
TTRAmyloidogenic transthyretin amyloidosisUncertain significance
(Oct 14, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr18:29171902
GRCh38:
Chr18:31591939
TTRG13RCarpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic,
Amyloidogenic transthyretin amyloidosis
Uncertain significance
(Jan 3, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr18:29172940
GRCh38:
Chr18:31592977
TTRH51NAmyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis,
Hyperthyroxinemia, dystransthyretinemic
Uncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr18:29172913
GRCh38:
Chr18:31592950
TTRG42SAmyloidogenic transthyretin amyloidosisUncertain significance
(Jul 12, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr18:29175196
GRCh38:
Chr18:31595233
TTRS105FHyperthyroxinemia, dystransthyretinemic, Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis,
Amyloidogenic transthyretin amyloidosis
Uncertain significance
(Jan 13, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr18:29172903
GRCh38:
Chr18:31592940
TTRD38ECardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic
(Apr 17, 2023)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr18:29178534
GRCh38:
Chr18:31598571
TTRV114LAmyloidogenic transthyretin amyloidosisUncertain significance
(Apr 27, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr18:29172910
GRCh38:
Chr18:31592947
TTRR41*Amyloidogenic transthyretin amyloidosisUncertain significance
(Jul 12, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr18:29172883-29172884
GRCh38:
Chr18:31592920-31592921
TTRAmyloidogenic transthyretin amyloidosisUncertain significance
(Jan 3, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr18:29178619
GRCh38:
Chr18:31598656
TTRV142AAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr18:29178561
GRCh38:
Chr18:31598598
TTRR123CHereditary ATTR amyloidosis, Amyloidogenic transthyretin amyloidosis, Cardiomyopathy
Uncertain significance
(Sep 24, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr18:29172872
GRCh38:
Chr18:31592909
TTRS28Fnot provided, Amyloidogenic transthyretin amyloidosisUncertain significance
(Sep 10, 2023)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr18:29175175
GRCh38:
Chr18:31595212
TTRY98FCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic/Likely pathogenic
(Sep 23, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr18:29172843
GRCh38:
Chr18:31592880
TTRAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotype, not provided
Conflicting interpretations of pathogenicity
(Sep 3, 2022)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr18:29171889
GRCh38:
Chr18:31591926
TTRnot provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
Benign/Likely benign
(Feb 3, 2023)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr18:29171851
GRCh38:
Chr18:31591888
TTRCardiovascular phenotype, not provided, Amyloidogenic transthyretin amyloidosis,
Carpal tunnel syndrome 1, Hyperthyroxinemia, dystransthyretinemic
Conflicting interpretations of pathogenicity
(Jul 8, 2021)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr18:29175096
GRCh38:
Chr18:31595133
TTRS72PAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic
(Aug 17, 2017)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr18:29175182
GRCh38:
Chr18:31595219
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Dec 25, 2020)
criteria provided, single submitter
81.
GRCh37:
Chr18:29178617
GRCh38:
Chr18:31598654
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Oct 16, 2019)
criteria provided, single submitter
82.
GRCh37:
Chr18:29171931
GRCh38:
Chr18:31591968
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Jan 29, 2019)
criteria provided, single submitter
83.
GRCh37:
Chr18:29175197
GRCh38:
Chr18:31595234
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Aug 31, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr18:29171905
GRCh38:
Chr18:31591942
TTRnot provided, Hyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis,
Carpal tunnel syndrome 1, Amyloidogenic transthyretin amyloidosis
Benign/Likely benign
(May 25, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr18:29178585
GRCh38:
Chr18:31598622
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Dec 17, 2019)
criteria provided, single submitter
86.
GRCh37:
Chr18:29172997
GRCh38:
Chr18:31593034
TTRAmyloidogenic transthyretin amyloidosisLikely benign
(Jan 30, 2020)
criteria provided, single submitter
87.
GRCh37:
Chr18:29172945
GRCh38:
Chr18:31592982
TTRAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypeLikely benign
(Jun 28, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr18:29172971
GRCh38:
Chr18:31593008
TTRW61LAmyloidogenic transthyretin amyloidosisPathogenic
(Sep 2, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr18:29172883
GRCh38:
Chr18:31592920
TTRL32VCardiovascular phenotype, Amyloidogenic transthyretin amyloidosisPathogenic
(Feb 24, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr18:29178575
GRCh38:
Chr18:31598612
TTRI127MAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypePathogenic/Likely pathogenic
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr18:29175207
GRCh38:
Chr18:31595244
TTRE109Knot provided, Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
Pathogenic/Likely pathogenic
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr18:29172975
GRCh38:
Chr18:31593012
TTRE62DAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr18:29175133
GRCh38:
Chr18:31595170
TTRF84SAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr18:29175099
GRCh38:
Chr18:31595136
TTRG73RAmyloidogenic transthyretin amyloidosisLikely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr18:29172968
GRCh38:
Chr18:31593005
TTRT60NAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypeLikely pathogenic
(Jan 26, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr18:29172974
GRCh38:
Chr18:31593011
TTRE62AAmyloidogenic transthyretin amyloidosisUncertain significance
(Nov 13, 2020)
no assertion criteria provided
97.
GRCh37:
Chr18:29178635
GRCh38:
Chr18:31598672
TTRnot provided, Amyloidogenic transthyretin amyloidosisLikely benign
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr18:29175223
GRCh38:
Chr18:31595260
TTRAmyloidogenic transthyretin amyloidosis, Cardiovascular phenotypeUncertain significance
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr18:29178555
GRCh38:
Chr18:31598592
TTRG121SHyperthyroxinemia, dystransthyretinemic, Amyloidogenic transthyretin amyloidosis, Carpal tunnel syndrome 1,
Amyloidogenic transthyretin amyloidosis, Cardiovascular phenotype
Uncertain significance
(Jun 15, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr18:29172993
GRCh38:
Chr18:31593030
TTRAmyloidogenic transthyretin amyloidosisUncertain significance
(Nov 17, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination